Allogeneic transplantation for multiple myeloma: further evidence for a GVHD-associated graft-versus-myeloma effect (Q34487436)

2 August 2017

1 reference

title

Allogeneic transplantation for multiple myeloma: further evidence for a GVHD-associated graft-versus-myeloma effect (English)

1 reference

2 August 2017

1 reference

Le Blanc R

1

1 reference

2 August 2017

Montminy-Métivier S

2

1 reference

2 August 2017

Bélanger R

3

1 reference

2 August 2017

Busque L

4

1 reference

2 August 2017

Fish D

5

1 reference

2 August 2017

Roy DC

6

1 reference

2 August 2017

Kassis J

7

1 reference

2 August 2017

Boileau J

8

1 reference

2 August 2017

Lavallée R

9

1 reference

2 August 2017

Bélanger D

10

1 reference

2 August 2017

Letendre F

11

1 reference

2 August 2017

Hébert J

12

1 reference

2 August 2017

Sauvageau G

13

1 reference

2 August 2017

Perreault C

14

1 reference

2 August 2017

Roy J

15

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

Bone Marrow Transplantation

2 August 2017

published in

1 reference

2 August 2017

volume

28

1 reference

2 August 2017

issue

9

1 reference

2 August 2017

page(s)

841-848

1 reference

Phase I study of busulfan and cyclophosphamide in preparation for allogeneic marrow transplant for patients with multiple myeloma

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703253

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703253

Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703253

Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703253

Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703253

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703253

HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia. European Group for Blood and Marrow Transplantation and the International Bone Marrow Transplant Registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703253

Donor lymphocyte infusions for relapsed multiple myeloma after allogeneic stem-cell transplantation: predictive factors for response and long-term outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703253

Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703253

Progress in allogeneic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983-93 and 1994-98 at European Group for Blood and Marrow Transplantation centres

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703253

Autologous and allogeneic transplantation for multiple myeloma at a single centre

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703253

7 January 2021

Allogeneic bone marrow transplantation in multiple myeloma. European Group for Bone Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703253

7 January 2021

Prognostic factors in allogeneic bone marrow transplantation for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703253

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703253

7 January 2021

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703253

7 January 2021

Combination chemotherapy, glucocorticoids, and interferon alfa in the treatment of multiple myeloma: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703253

7 January 2021

Allogeneic transplantation of unmanipulated peripheral blood stem cells in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703253

7 January 2021

Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic stem cell transplantation in newly diagnosed multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703253

7 January 2021

High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703253

7 January 2021

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703253

7 January 2021

Immunodominant minor histocompatibility antigens: the major ones

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703253

7 January 2021

Adjuvant alpha-interferon improves complete remission rates following allogeneic transplantation for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703253

7 January 2021

Real-Time polymerase chain reaction of immunoglobulin rearrangements for quantitative evaluation of minimal residual disease in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703253

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1703253

1 reference

Dimensions Publication ID

2 August 2017

1039030248

0 references

1 reference